The University of California, Berkeley, in partnership with Universities Allied for Essential Medicines (UAEM) and the Medicines Patent Pool (MPP), has released and posted a new License agreement template that includes affordable access plan (AAP) provisions for health technologies developed by university researchers. The agreement language has been used previously by the university and is designed to require eventual licensees to create an actionable plan to ensure health technologies are accessible to people in low- and middle-income countries, and to address major inequities in communities across the United States.

Come join panelists from UAEM and the University of California Berkeley Intellectual Property & Industry Research Alliances to talk about what this policy means for university licensing at Berkeley and beyond.